CD94 (CD94) Antibody |
abx139673-01mg |
Abbexa |
0.1 mg |
EUR 427.2 |
|
Human IgG antibody Laboratories manufactures the nkg2a/cd94 protein novoprotein reagents distributed by Genprice. The Nkg2A/Cd94 Protein Novoprotein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Novoprotein. Other Nkg2A/Cd94 products are available in stock. Specificity: Nkg2A/Cd94 Category: Protein Group: Novoprotein
Recombinant Human CD94 Protein |
MyBiosource |
0.05mg |
EUR 575 |
Recombinant Human CD94 Protein |
MyBiosource |
0.5mg |
EUR 2510 |
Recombinant Human CD94 Protein |
MyBiosource |
5x0.5mg |
EUR 11220 |
Anti-Human CD94 Antibody |
ReliaTech |
100 µg |
EUR 399 |
Description: The type-II transmembrane glycoprotein CD94 covalently associates with C-type lectins of the NKG2 family to yield heterodimers important in NK cell recognition of class I MHC molecules. CD94/NKG2A complexes are also found on a subset of CD8+ T cells. Expression of CD94/NKG2 heterodimers may regulate cell survival and effector functions. There are two alternatively spliced variants of CD94 that differ by 31 amino acids encoded by exon 2. |
CD94 antibody |
Fitzgerald |
100 ug |
EUR 344 |
|
Description: Mouse monoclonal CD94 antibody |
CD94 antibody |
Fitzgerald |
100 ug |
EUR 344 |
|
Description: Mouse Monoclonal CD94 antibody |
CD94 antibody |
Fitzgerald |
500 ug |
EUR 315 |
|
Description: Rat monoclonal CD94 antibody |
Novoprotein information
Human NKG2A/CD94 HEK293 Cell Line |
E24C00247 |
EnoGene |
each |
EUR 1225 |
Description: Human |
Recombinant Human NKG2A & CD94 Heterodimer protein (N-8His) & N-Flag |
CD01214-10ug |
Jiaxing Korain Biotech Ltd (BT Labs) |
10ug |
EUR 223 |
|
Description: Recombinant Human Human NKG2A & CD94 Heterodimer is produced by our Mammalian expression system and the target gene encoding Arg100-Leu233 & Ser34-Ile179 is expressed with a 8His, Flag tag at the N-terminus. |
Recombinant Human NKG2A & CD94 Heterodimer protein (N-8His) & N-Flag |
CD01214-50ug |
Jiaxing Korain Biotech Ltd (BT Labs) |
50ug |
EUR 588 |
|
Description: Recombinant Human Human NKG2A & CD94 Heterodimer is produced by our Mammalian expression system and the target gene encoding Arg100-Leu233 & Ser34-Ile179 is expressed with a 8His, Flag tag at the N-terminus. |
Recombinant Human NKG2A & CD94 Heterodimer Protein (N-8His & N-DYKDDDDK) |
MBS2553014-001mg |
MyBiosource |
0.01mg |
EUR 170 |
Recombinant Human NKG2A & CD94 Heterodimer Protein (N-8His & N-DYKDDDDK) |
MBS2553014-005mg |
MyBiosource |
0.05mg |
EUR 305 |
Recombinant Human NKG2A & CD94 Heterodimer Protein (N-8His & N-DYKDDDDK) |
MBS2553014-5x005mg |
MyBiosource |
5x0.05mg |
EUR 1365 |
Recombinant Human NKG2-A/NKG2-B Type II Integral Membrane Protein(N-8His) |
CB20-10ug |
Novoprotein |
10ug |
EUR 96 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human NKG2-A/NKG2-B Type II Integral Membrane Protein(N-8His) |
CB20-1mg |
Novoprotein |
1mg |
EUR 1216.8 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human NKG2-A/NKG2-B Type II Integral Membrane Protein(N-8His) |
CB20-500ug |
Novoprotein |
500ug |
EUR 790.8 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human NKG2-A/NKG2-B Type II Integral Membrane Protein(N-8His) |
CB20-50ug |
Novoprotein |
50ug |
EUR 169.2 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human NKG2-D type II Integral Membrane Protein/NKG2D/CD314 (N-6His) |
CP46-10ug |
Novoprotein |
10ug |
EUR 175.2 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human NKG2-D type II Integral Membrane Protein/NKG2D/CD314 (N-6His) |
CP46-1mg |
Novoprotein |
1mg |
EUR 2739.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human NKG2-D type II Integral Membrane Protein/NKG2D/CD314 (N-6His) |
CP46-500ug |
Novoprotein |
500ug |
EUR 1935.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human NKG2-D type II Integral Membrane Protein/NKG2D/CD314 (N-6His) |
CP46-50ug |
Novoprotein |
50ug |
EUR 363.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
NKG2A / CD159a Recombinant Protein |
11-287 |
ProSci |
0.1 mg |
EUR 714.3 |
Description: NKG2A/CD159a is a transmembrane protein belonging to the CD94/NKG2 family of C-type lectin-like receptors that inhibits innate immune system activation, also known as KLRC1, CD159a, NK cell receptor A and NKG2-A/NKG2-B type II integral membrane protein. NKG2A marks a unique immune effector subset preferentially co-expressing the tissue-resident CD103 molecule, but not immune checkpoint inhibitors. NKG2A blockade therapy operated through CD8 T cells, but not NK cells. The increase in NKG2A expression might be induced by IL-10, which was present at a high level in the plasma of HCC patients. Blocking IL-10 could specifically inhibit NKG2A expression in NK cells. These findings indicate that NKG2A expression is influenced by factors from cancer nests and contributes to NK cell exhaustion, suggesting that NKG2A blockade has the potential to restore immunity against liver tumors by reversing NK cell exhaustion. |
NKG2A / CD159a Recombinant Protein |
11-313 |
ProSci |
0.1 mg |
EUR 714.3 |
Description: NKG2A/CD159a is a transmembrane protein belonging to the CD94/NKG2 family of C-type lectin-like receptors that inhibits innate immune system activation, also known as KLRC1, CD159a, NK cell receptor A and NKG2-A/NKG2-B type II integral membrane protein. NKG2A marks a unique immune effector subset preferentially co-expressing the tissue-resident CD103 molecule, but not immune checkpoint inhibitors. NKG2A blockade therapy operated through CD8 T cells, but not NK cells. The increase in NKG2A expression might be induced by IL-10, which was present at a high level in the plasma of HCC patients. Blocking IL-10 could specifically inhibit NKG2A expression in NK cells. These findings indicate that NKG2A expression is influenced by factors from cancer nests and contributes to NK cell exhaustion, suggesting that NKG2A blockade has the potential to restore immunity against liver tumors by reversing NK cell exhaustion. |
Human NKG2A/CD94 NFκB luci Jurkat Cell Line |
E24C00245 |
EnoGene |
each |
EUR 1225 |
|
Description: Human |